| Exhibitor | Stand no. (List as per 26 August 2019) |
|---|---|
| ACTRIMS | A50 |
| Alexion Pharmaceuticals Inc | C68 |
| Almirall, S.A. | C64 |
| Barts MS-Clinic Speak | D20 |
| Bayer AG | C40 |
| Biogen International GmbH | B20 |
| Celgene International | C50 |
| COMBAT-MS | D24 |
| CorTechs Labs | B01 |
| EDMUS Foundation-OFSEP | D32 |
| European Charcot Foundation (Seauton) | D70 |
| European Multiple Sclerosis Platform (EMSP) | D03 |
| F. Hoffmann-La Roche Ltd. | B10 |
| F. Hoffmann-La Roche Ltd. | B12 |
| F. Hoffmann-La Roche Ltd. / Shift.ms | C02 |
| Guthy-Jackson Charitable Foundation | D05 |
| HRA Healthcare Research & Analytics | B03 |
| icometrix | B05 |
| Italian MS Registry | D33 |
| Janssen Research & Development | C70 |
| jung diagnostics GmbH | D64 |
| Medday Pharmaceuticals SA | C60 |
| Merck | B40 |
| MIDATA | D21 |
| Mollii | D62 |
| MS Brain Health | D63 |
| MS Data Alliance | D71 |
| MS Experience | B50 |
| MS Forschungs- und Projektentwicklungs-gGmbH | D25 |
| MS International Federation | D51 |
| MSBase Registry(MSBase Foundation Ltd) | D34 |
| Neuro-Compass | D60 |
| Novartis Pharma AG | C10 |
| Novartis Pharma AG | C20 |
| Qmenta | A40 |
| Quanterix | A42 |
| Quantib BV | D07 |
| Qynapse | C04 |
| RIMS | D52 |
| SAGE Publishing | D04 |
| Sanofi Genzyme | C30 |
| Swedish MS Registry | D30 |
| Sydney Neuroimaging Analysis Centre | D08 |
| Teva Pharmaceuticals Europe BV | B30 |
| The Danish Mutilple Sclerosis Registry | D31 |
| The Social Network for Msers | D53 |
| UK MS Register / MS Tissue Bank | D06 |
| Ung med MS | D23 |
| Viela Bio | C74 |
| Wisepress Ltd | D50 |
| Zero Gravity Skin | C06 |
